Holm E, Zetterberg E, Lovdahl S, Berntorp E
Mediterr J Hematol Infect Dis. 2016; 8(1):e2016014.
PMID: 26977273
PMC: 4771142.
DOI: 10.4084/MJHID.2016.014.
Alexandre P, LARCAN A, Briquel M
Blut. 1980; 41(6):437-44.
PMID: 6778541
DOI: 10.1007/BF01007768.
Seifried E, Pindur G, Stotter H, Wiesneth M, Rasche H, Heimpel H
Blut. 1984; 48(6):369-76.
PMID: 6540131
DOI: 10.1007/BF00319965.
Scharrer I
Blut. 1983; 47(3):123-30.
PMID: 6411153
DOI: 10.1007/BF00320173.
ROBERTSON C, Chang H
Ann Biomed Eng. 1974; 2(4):361-91.
PMID: 4458566
DOI: 10.1007/BF02368095.
[The continuous measurement of platelet aggregation without addition of aggregation stimulators. I. Methods and clinical results].
Jager W, Kutschera J, Wendeberg H, Kauschmann R, RIESE W, Pietsch U
Blut. 1974; 29(3):184-94.
PMID: 4411130
DOI: 10.1007/BF01634121.
The use of blood components in surgical transfusion therapy.
HOGMAN C, BAGGE L, Thoren L
World J Surg. 1987; 11(1):2-13.
PMID: 3811383
DOI: 10.1007/BF01658452.
ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.
Bradbrook I, Magnani H, Moelker H, Morrison P, Robinson J, Rogers H
Br J Clin Pharmacol. 1987; 23(6):667-75.
PMID: 3606928
PMC: 1386160.
DOI: 10.1111/j.1365-2125.1987.tb03100.x.
Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases.
Anger B, Seifried E, Scheppach J, Heimpel H
Klin Wochenschr. 1989; 67(16):818-25.
PMID: 2796252
DOI: 10.1007/BF01725198.
Role of endothelium-derived nitric oxide in the bleeding tendency of uremia.
Remuzzi G, Perico N, Zoja C, Corna D, Macconi D, Vigano G
J Clin Invest. 1990; 86(5):1768-71.
PMID: 2243146
PMC: 296932.
DOI: 10.1172/JCI114904.
Influence of splenectomy on platelet morphometry and function.
Wehmeier A, Scharf R, Schneider W
Klin Wochenschr. 1990; 68(17):847-52.
PMID: 2214608
DOI: 10.1007/BF01662780.
[The effect of acetylsalicylic-lysine on platelet function (author's transl)].
Schondorf T
Klin Wochenschr. 1975; 53(23):1125-9.
PMID: 1206970
DOI: 10.1007/BF01614281.
[Von Willebrand-Jürgens syndrome with a variant of factor VIII-associated antigen].
Bottcher D, Hasler K, Sutor A, Mair D
Blut. 1976; 33(1):33-40.
PMID: 1086110
DOI: 10.1007/BF01005210.
[Willebrand's disease and platelet adhesiveness in the presence of ristocetine].
Alexander P, Streiff F, Stoltz J, Andre E
Blut. 1975; 31(2):87-94.
PMID: 1080678
DOI: 10.1007/BF01633724.
Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.
Rasi V, Torstila I
Proc R Soc Med. 1976; 69 Suppl 2:109-11.
PMID: 1019149
PMC: 1864038.
Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor.
Dumont M, Intrator L, Chenal C, Lejonc J
J Clin Pathol. 1979; 32(10):1030-5.
PMID: 316435
PMC: 1145886.
DOI: 10.1136/jcp.32.10.1030.
von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
Montgomery R, ZIMMERMAN T
J Clin Invest. 1978; 61(6):1498-507.
PMID: 307007
PMC: 372676.
DOI: 10.1172/JCI109070.
Bleeding in renal failure: is von Willebrand factor implicated?.
Remuzzi G, Livio M, Roncaglioni M, MECCA G, Donati M, de Gaetano G
Br Med J. 1977; 2(6083):359-61.
PMID: 302134
PMC: 1631138.
DOI: 10.1136/bmj.2.6083.359.
